These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7940820)
21. First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation. Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL Transplant Proc; 1992 Oct; 24(5):2241-2. PubMed ID: 1413040 [No Abstract] [Full Text] [Related]
22. Conversion of cyclosporine to azathroprine in renal transplant recipients. Bassiri A; Amiranssari B; Gol S Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877 [No Abstract] [Full Text] [Related]
23. A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine/prednisolone during the maintenance phase of immunosuppression. Park K; Kim ST; Lee SR; Koh YB; Kim HC Transplant Proc; 1994 Aug; 26(4):1985-6. PubMed ID: 8066642 [No Abstract] [Full Text] [Related]
24. Live donor renal transplantation with low-dose triple immunosuppression. Francis DM; Millar RJ; Walker RG; Nicholls K; Powell H; Jones C; Kockelbergh R; Becker G Transplant Proc; 1992 Oct; 24(5):2243. PubMed ID: 1413041 [No Abstract] [Full Text] [Related]
25. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression. Pallardó LM; Sánchez P; Sánchez J; García J; Beneyto I; Orero E; Rochera A Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781 [No Abstract] [Full Text] [Related]
26. The effects of pravastatin on hyperlipidemia in renal transplant recipients. Yoshimura N; Oka T; Okamoto M; Ohmori Y Transplantation; 1992 Jan; 53(1):94-9. PubMed ID: 1733092 [TBL] [Abstract][Full Text] [Related]